{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:12:56Z","timestamp":1793416376491,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal dominant vascular disorder characterized by mucocutaneous telangiectasias and arteriovenous malformations (AVMs) in internal organs. It is mainly caused by heterozygous pathogenic variants in\n                    <jats:italic>ENG<\/jats:italic>\n                    ,\n                    <jats:italic>ACVRL1<\/jats:italic>\n                    or\n                    <jats:italic>SMAD4<\/jats:italic>\n                    . Somatic mosaic mutations in the functional allele of HHT-causing genes have been identified in skin telangiectasias and AVMs of HHT patients, which is suspected to drive formation of telangiectasias and AVMs. Our objective was to further support and clarify the pathogenetic mechanism of HHT lesion genesis by analysing several HHT lesion biopsies; all from a single HHT patient caused by a germline deletion of the entire\n                    <jats:italic>ACVRL1<\/jats:italic>\n                    gene. Deep exome sequencing was performed on DNA from multiple fresh tissue biopsies from the same HHT patient; six hepatic AVM samples, two macroscopic normal hepatic control samples, and three mucocutaneous telangiectasia biopsies. Somatic mosaic lesion-specific\n                    <jats:italic>ACVRL1<\/jats:italic>\n                    variants were identified in four hepatic AVM samples and in one telangiectasia. Two different somatic variants (c.293A&gt;G; p.Asn98Ser and c.1378-199C&gt;A) were identified in several lesions from the same liver. Additionally, a third lesion-specific somatic variant (c.614T&gt;G; p.Val205Gly) was identified in one skin telangiectasia. We identified in total 3 different somatic variants, which are expected to contribute to the pathogenesis of HHT vascular lesions. These data further support the second-hit pathophysiological mechanism to explain the multifocality of vascular lesions in HHT. This is the first report to perform deep sequencing on multiple samples from both several visceral AVMs and telangiectasias originating from one single HHT patient.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01962-2","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:20:47Z","timestamp":1761754847000},"page":"236-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multiple lesion-specific somatic mutations and bi-allelic loss of ACVRL1 in a single patient with hereditary haemorrhagic telangiectasia"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2562-127X","authenticated-orcid":false,"given":"Pernille","family":"Darre Haahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-2181","authenticated-orcid":false,"given":"Qin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-4988","authenticated-orcid":false,"given":"Klaus","family":"Brusgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4107-8771","authenticated-orcid":false,"given":"Martin Jakob","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette Dam","family":"Fialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Seremet","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-6572","authenticated-orcid":false,"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai Aagaard","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0593-6302","authenticated-orcid":false,"given":"Anette Dr\u00f8hse","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7303-7619","authenticated-orcid":false,"given":"Pernille Mathiesen","family":"T\u00f8rring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"1962_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0008-6363(02)00852-0","volume":"58","author":"S van den Driesche","year":"2003","unstructured":"van den Driesche S, Mummery CL, Westermann CJ. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res. 2003;58:20\u201331.","journal-title":"Cardiovasc Res"},{"key":"1962_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pediatrneurol.2024.03.013","volume":"155","author":"LA Beslow","year":"2024","unstructured":"Beslow LA, Krings T, Kim H, Hetts SW, Lawton MT, Ratjen F, et al. De novo brain vascular malformations in hereditary hemorrhagic telangiectasia. Pediatr Neurol. 2024;155:120\u20135.","journal-title":"Pediatr Neurol"},{"key":"1962_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/ijd.16320","volume":"61","author":"SJ Hyldahl","year":"2022","unstructured":"Hyldahl SJ, El-Jaji MQ, Schuster A, Kjeldsen AD. Skin and mucosal telangiectatic lesions in hereditary hemorrhagic telangiectasia patients. Int J Dermatol. 2022;61:1497\u2013505.","journal-title":"Int J Dermatol"},{"key":"1962_CR4","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/ajmg.a.32243","volume":"146A","author":"TG Letteboer","year":"2008","unstructured":"Letteboer TG, Mager HJ, Snijder RJ, Lindhout D, Ploos van Amstel HK, Zanen P, et al. Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. Am J Med Genet A. 2008;146A:2733\u20139.","journal-title":"Am J Med Genet A"},{"key":"1962_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345\u201351.","journal-title":"Nat Genet"},{"key":"1962_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852\u20139.","journal-title":"Lancet"},{"key":"1962_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/gr.5.1.21","volume":"5","author":"DW Johnson","year":"1995","unstructured":"Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res. 1995;5:21\u20138.","journal-title":"Genome Res"},{"key":"1962_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91:66\u20137.","journal-title":"Am J Med Genet"},{"key":"1962_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43:97\u2013110.","journal-title":"J Med Genet"},{"key":"1962_CR10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/hmg\/8.12.2171","volume":"8","author":"N Pece-Barbara","year":"1999","unstructured":"Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet. 1999;8:2171\u201381.","journal-title":"Hum Mol Genet"},{"key":"1962_CR11","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1172\/JCI119800","volume":"100","author":"N Pece","year":"1997","unstructured":"Pece N, Vera S, Cymerman U, White RI Jr, Wrana JL, Letarte M. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest. 1997;100:2568\u201379.","journal-title":"J Clin Invest"},{"key":"1962_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1962_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings DA, Gallione CJ, Clark DS, Vozoris NT, Faughnan ME, Marchuk DA. Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1. Am J Hum Genet. 2019;105:894\u2013906.","journal-title":"Am J Hum Genet"},{"key":"1962_CR14","doi-asserted-by":"crossref","unstructured":"Whitehead KJ, Toydemir D, Wooderchak-Donahue W, Oakley GM, McRae B, Putnam A, et al. Investigation of the genetic determinants of telangiectasia and solid organ arteriovenous malformation formation in Hereditary Hemorrhagic Telangiectasia (HHT). Int J Mol Sci. 2024;25:7682.","DOI":"10.3390\/ijms25147682"},{"key":"1962_CR15","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.ajhg.2024.08.020","volume":"111","author":"E DeBose-Scarlett","year":"2024","unstructured":"DeBose-Scarlett E, Ressler AK, Gallione CJ, Sapisochin Cantis G, Friday C, Weinsheimer S, et al. Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis. Am J Hum Genet. 2024;111:2283\u201398.","journal-title":"Am J Hum Genet"},{"key":"1962_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/jmg-2024-110569","volume":"62","author":"E DeBose-Scarlett","year":"2025","unstructured":"DeBose-Scarlett E, Ressler AK, Friday C, Prickett KK, Roberts JW, Gossage JR, et al. Arteriovenous malformation from a patient with JP-HHT harbours two second-hit somatic DNA alterations in SMAD4. J Med Genet. 2025;62:281\u20138.","journal-title":"J Med Genet"},{"key":"1962_CR17","doi-asserted-by":"crossref","unstructured":"Bernabeu C, Bayrak-Toydemir P, McDonald J, Letarte M. Potential second-hits in hereditary hemorrhagic telangiectasia. J Clin Med. 2020;9:3571.","DOI":"10.3390\/jcm9113571"},{"key":"1962_CR18","doi-asserted-by":"publisher","first-page":"973964","DOI":"10.3389\/fmed.2022.973964","volume":"9","author":"HM Arthur","year":"2022","unstructured":"Arthur HM, Roman BL. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms. Front Med (Lausanne). 2022;9:973964.","journal-title":"Front Med (Lausanne)"},{"key":"1962_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ajmg.a.37613","volume":"170","author":"CF Macmurdo","year":"2016","unstructured":"Macmurdo CF, Wooderchak-Donahue W, Bayrak-Toydemir P, Le J, Wallenstein MB, Milla C, et al. RASA1 somatic mutation and variable expressivity in capillary malformation\/arteriovenous malformation (CM\/AVM) syndrome. Am J Med Genet A. 2016;170:1450\u20134.","journal-title":"Am J Med Genet A"},{"key":"1962_CR20","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/1346-8138.14676","volume":"45","author":"R Cai","year":"2018","unstructured":"Cai R, Liu F, Liu Y, Chen H, Lin X. RASA-1 somatic \u201csecond hit\u201d mutation in capillary malformation-arteriovenous malformation. J Dermatol. 2018;45:1478\u201380.","journal-title":"J Dermatol"},{"key":"1962_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-2004-813549","volume":"25","author":"E Buscarini","year":"2004","unstructured":"Buscarini E, Danesino C, Olivieri C, Lupinacci G, De Grazia F, Reduzzi L, et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia - results of extensive screening. Ultraschall Med. 2004;25:348\u201355.","journal-title":"Ultraschall Med"},{"key":"1962_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/3043736","volume":"2024","author":"D DeMille","year":"2024","unstructured":"DeMille D, McDonald J, Bernabeu C, Racher H, Olivieri C, Cantarini C, et al. specifications of the ACMG\/AMP variant curation guidelines for hereditary hemorrhagic telangiectasia genes\u2014ENG and ACVRL1. Human Mutat. 2024;2024:3043736.","journal-title":"Human Mutat"},{"key":"1962_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/cge.12269","volume":"86","author":"PM Torring","year":"2014","unstructured":"Torring PM, Brusgaard K, Ousager LB, Andersen PE, Kjeldsen AD. National mutation study among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2014;86:123\u201333.","journal-title":"Clin Genet"},{"key":"1962_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jmg.2006.042606","volume":"43","author":"NL Prigoda","year":"2006","unstructured":"Prigoda NL, Savas S, Abdalla SA, Piovesan B, Rushlow D, Vandezande K, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet. 2006;43:722\u20138.","journal-title":"J Med Genet"},{"key":"1962_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1399-0004.2008.01029.x","volume":"74","author":"K Brakensiek","year":"2008","unstructured":"Brakensiek K, Frye-Boukhriss H, Malzer M, Abramowicz M, Bahr MJ, von Beckerath N, et al. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2008;74:171\u20137.","journal-title":"Clin Genet"},{"key":"1962_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01422-8","volume":"15","author":"R Sanchez-Martinez","year":"2020","unstructured":"Sanchez-Martinez R, Iriarte A, Mora-Lujan JM, Patier JL, Lopez-Wolf D, Ojeda A, et al. Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry. Orphanet J Rare Dis. 2020;15:138.","journal-title":"Orphanet J Rare Dis"},{"key":"1962_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/jhg.2013.113","volume":"59","author":"M Komiyama","year":"2014","unstructured":"Komiyama M, Ishiguro T, Yamada O, Morisaki H, Morisaki T. Hereditary hemorrhagic telangiectasia in Japanese patients. J Hum Genet. 2014;59:37\u201341.","journal-title":"J Hum Genet"},{"key":"1962_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-01139-y","volume":"14","author":"K Kitayama","year":"2021","unstructured":"Kitayama K, Ishiguro T, Komiyama M, Morisaki T, Morisaki H, Minase G, et al. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia. BMC Med Genom. 2021;14:288.","journal-title":"BMC Med Genom"},{"key":"1962_CR29","first-page":"427","volume":"53","author":"NM Douarin","year":"1975","unstructured":"Douarin NM. An experimental analysis of liver development. Med Biol. 1975;53:427\u201355.","journal-title":"Med Biol"},{"key":"1962_CR30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0168-8278(02)00282-9","volume":"37","author":"G Gouysse","year":"2002","unstructured":"Gouysse G, Couvelard A, Frachon S, Bouvier R, Nejjari M, Dauge MC, et al. Relationship between vascular development and vascular differentiation during liver organogenesis in humans. J Hepatol. 2002;37:730\u201340.","journal-title":"J Hepatol"},{"key":"1962_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/rg.243035046","volume":"24","author":"C Gallego","year":"2004","unstructured":"Gallego C, Miralles M, Marin C, Muyor P, Gonzalez G, Garcia-Hidalgo E. Congenital hepatic shunts. Radiographics. 2004;24:755\u201372.","journal-title":"Radiographics"},{"key":"1962_CR32","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012\u201327.","journal-title":"Trends Genet"},{"key":"1962_CR33","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/ijc.23882","volume":"123","author":"VC Wong","year":"2008","unstructured":"Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL, et al. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma. Int J Cancer. 2008;123:2816\u201323.","journal-title":"Int J Cancer"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01962-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01962-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01962-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:46:10Z","timestamp":1769769970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01962-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01962-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6438890\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The project has been approved by the Danish Ethics Committee, project-ID S-20230085. Information about the project was provided both orally and in writing, and a written informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}